Whiting Ellis, Raje Mithun R, Chauhan Jay, Wilder Paul T, Van Eker Daniel, Hughes Samuel J, Bowen Nathan G, Vickers Gregory E A, Fenimore Ian C, Fletcher Steven
School of Chemistry, University of Cardiff, Cardiff CF10 3AT, UK.
Department of Pharmaceutical Sciences, University of Maryland School of Pharmacy, 20 N Pine St., Baltimore, MD 21201, United States.
Bioorg Med Chem Lett. 2018 Feb 1;28(3):523-528. doi: 10.1016/j.bmcl.2017.11.023. Epub 2017 Dec 12.
Inspired by a rhodanine-based dual inhibitor of Bcl-x and Mcl-1, a focused library of analogues was prepared wherein the rhodanine core was replaced with a less promiscuous thiazolidine-2,4-dione scaffold. Compounds were initially evaluated for their abilities to inhibit Mcl-1. The most potent compound 12b inhibited Mcl-1 with a K of 155 nM. Further investigation revealed comparable inhibition of Bcl-x (K = 90 nM), indicating that the dual inhibitory profile of the initial rhodanine lead had been retained upon switching the heterocycle core.
受一种基于若丹宁的Bcl-x和Mcl-1双重抑制剂的启发,制备了一个类似物的聚焦文库,其中若丹宁核心被一个不太混杂的噻唑烷-2,4-二酮支架所取代。最初对化合物抑制Mcl-1的能力进行了评估。最有效的化合物12b以155 nM的K值抑制Mcl-1。进一步研究表明对Bcl-x有类似的抑制作用(K = 90 nM),这表明在切换杂环核心后,最初若丹宁先导化合物的双重抑制特性得以保留。